Navigation Links
Brookstone Pharmaceuticals Appoints New Corporate Position
Date:7/30/2009

ALPHARETTA, Ga., July 30 /PRNewswire/ -- Brookstone Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced the appointment of Philip Vogt as Executive Vice President, Sales and Marketing.

Vogt brings more than thirty years of pharmaceutical experience and will lead the sales and marketing effort within Brookstone. Prior to this role, Vogt served as President of Ethex Corporation in St. Louis, MO. Vogt developed initiatives to expand presence in new therapeutic markets and introduced proactive, customer-focused practices to deliver value and enhance relationships with trading partners. Other positions held include: Vice President, Marketing and National Sales Manager. Vogt received a B.S. in Business Administration from Louisiana State University.

"The appointment of Philip demonstrates our continued commitment to a growth strategy planned around excellence and strength. We look forward to developing Brookstone as a company of distinction, built with the highest caliber of integrity and talent in the market," said Mark Pugh, CEO Brookstone Pharmaceuticals.


'/>"/>
SOURCE Brookstone Pharmaceuticals, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... India , January 24, 2017 According to ... Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, ... to 2021", published by MarketsandMarkets, the global market is expected to reach ... a CAGR of 12.4% from 2016 to 2021. ... ...
(Date:1/24/2017)... 2017  Bruker today announced that it ... in the development, manufacture, and sale of ... innovative nanomechanical testing instruments to Bruker,s existing ... profilometers, and tribology and mechanical testing systems, ... research markets. Hysitron,s 2016 revenues were approximately ...
(Date:1/24/2017)... ... January 24, 2017 , ... Amendia, Inc., designer, developer, ... F. McAllister as Executive Vice President and Chief Financial Officer. , Steve has ... markets. Beginning his career at Howmedica, Inc., he has since served in various ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... available malaria Plasmodium falciparum culture panels with standard concentrations of histidine rich protein ... available in a range of concentrations from six different malaria strains, are intended ...
Breaking Biology Technology:
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
(Date:1/12/2017)... Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... technologies, today announced that it has signed agreements with ... and the Middle East for ... marks the first wave of international distribution agreements for ... blood samples. The initial partners will introduce ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
Breaking Biology News(10 mins):